Original Article
The application of real-time indocyanine green fluorescence cholangiography in laparoscopic living donor left lateral sectionectomy
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:575-585
.
(01 August 2024)
PDF
Full Text
(1213)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
ICG fluorescence cholangiography avoided the biliary complications in both donors and its relevant recipients and is recommended for routine use in LLLS.
Immunosuppression and phenotypic plasticity in an atlas of human hepatocholangiocarcinoma
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:586-603
.
(01 August 2024)
We used single-cell RNA sequencing data analysis to systematically compare the transcriptomic signatures of different cell populations in HCC, iCCA and H-ChC, which revealed the molecular mechanisms underlying the coexistence of HCC and iCCA components in H-ChC.
The differential benefit of laparoscopic over open minor liver resection for lesions situated in the anterolateral or posterosuperior segments
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:604-615
.
(01 August 2024)
PDF
Full Text
(1031)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
Laparoscopic surgery offers several benefits over open surgery when adopted for minor liver resections in the AL and PS segments. The advantage of laparoscopy is however greater in the AL segments. In centers with the appropriate experience, the minimally invasive approach should thus increasingly be adopted to perform minor liver resections irrespective of the location of the lesion(s).
Adjuvant camrelizumab plus apatinib in resected hepatocellular carcinoma with microvascular invasion: a multi-center real world study
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:616-631
.
(01 August 2024)
PDF
Full Text
(1838)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
Camrelizumab plus Apatinib has shown significant efficacy in improving RFS as a postoperative adjuvant regimen for patients with MVI-positive HCC. The favorable safety makes the combination an alternative adjunctive regimen for HCC patients after hepatectomy.
Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:632-649
.
(01 August 2024)
PDF
Full Text
(1094)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
Residual insulin resistance and high total bile acid levels were identified as risk factors for subsequent diminished sustained improvements of steatosis and fibrosis in MASLD patients, respectively. This provides potential guidance for clinicians in preventing patients against loss of treatment response in MASLD.
Review Article
A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:650-661
.
(01 August 2024)
This review provides a comprehensive and updated review of research on the genetics and epigenetic mechanisms implicated in developing Hepatocellular carcinoma (HCC) associated with Hepatitis C infection (HCV) infection. We also discuss the potential translational implications, including novel biomarkers and drugs for treatment.
Surgical Technique
Beyond the Rex: an innovative meso-intrahepatic portal vein bypass for late-onset extrahepatic portal vein occlusion after living donor liver transplantation
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:662-668
.
(01 August 2024)
The MIPVB is an innovative technique to address EHPVO especially in patients with a Rex recess that is not safely accessible and with symptoms refractory to conventional surgical strategies. Furthermore, it is potentially useful for the right liver graft.
French Editorial Commentary from the ACHBPT
Feasibility and outcomes of robotic partial pancreatoduodenectomy
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:669-671
.
(01 August 2024)
Can we talk about “futile surgery” for the upfront treatment of the perihilar cholangiocarcinoma?
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:672-674
.
(01 August 2024)
To drain or not to drain after distal pancreatectomy: reflexions on the PANDORINA trial
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:675-677
.
(01 August 2024)
Editorial Commentary
Does ischemia-free machine perfusion lead to early allograft dysfunction (EAD) free liver transplantation?
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:678-680
.
(01 August 2024)
Long-term normothermic machine perfusion of fatty livers: towards transplanting untransplantable livers?
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:681-685
.
(01 August 2024)
Liver microbiome: an intrahepatic resident playing a role in liver diseases
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:686-689
.
(01 August 2024)
Advocating for the implementation of SonoVue microbubbles as pressure sensors: a call to action for clinical noninvasive pressure estimation
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:690-695
.
(01 August 2024)
Critical appraisal of novel prediction models and risk calculators for post-hepatectomy liver failure and complications: practicability and generalisability in the real-world setting
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:696-698
.
(01 August 2024)
High risk of thrombosis recurrence in people with idiopathic or only locally caused non-cirrhotic splanchnic vein thrombosis: it is time for guidelines’ revision
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:699-702
.
(01 August 2024)
Minimally invasive liver resection in metabolic syndrome: insights and future directions
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:703-705
.
(01 August 2024)
Parenchymal sparing anatomical liver resections for hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:706-708
.
(01 August 2024)
Standardization is needed in reporting risk and outcomes of machine perfusion in liver transplantation
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:709-714
.
(01 August 2024)
Understanding acute kidney injury (AKI) in liver cirrhosis from the acute-on-chronic liver failure (ACLF) perspective
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:715-717
.
(01 August 2024)
Right or left hepatectomy: a continuing question in the era of pure laparoscopic donor hepatectomy
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:718-720
.
(01 August 2024)
Pioneering the future of robotic liver surgery
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:721-723
.
(01 August 2024)
Advances and controversies in the management of acute cholecystitis in high-risk, critically ill, and unfit-for-surgery patients: the Italian Society of Emergency Surgery and Trauma guidelines
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:724-726
.
(01 August 2024)
Editorial
Trimming the fat myth: adipose tissue’s role in liver regeneration
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:727-731
.
(01 August 2024)
Outcome prediction after resection of colorectal cancer liver metastases: out with the old, in with the new?
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:732-735
.
(01 August 2024)
Prognosis of operated hepatocellular carcinoma developed on non-cirrhotic liver
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:736-738
.
(01 August 2024)
Cross-continental insights into liver cancer: an East vs. West epidemiology
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:739-741
.
(01 August 2024)
Living donor liver transplantation can be a rescue treatment for hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:742-744
.
(01 August 2024)
Risk of early hepatocellular carcinoma recurrence following liver resection: arbitrary specification or possible target to improve outcome?
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:745-748
.
(01 August 2024)
Viewpoint
Use of discarded liver in living-donor liver transplantation
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:749-751
.
(01 August 2024)
Letter to the Editor
A machine learning model for colorectal liver metastasis post-hepatectomy prognostications: several strategies for the model evaluation
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:752-754
.
(01 August 2024)
The validity of serum ferritin levels in predicting cardiovascular events of metabolic dysfunction-associated steatotic liver disease patients may need more consideration
HepatoBiliary Surgery and Nutrition
2024;
13
(4)
:755-756
.
(01 August 2024)
